TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/YZacks Investment Research • 10/30/25
TransMedics (TMDX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/30/25
Heart Transplant Play Nears Buy Point. Analysts See Earnings Surging Again.Investors Business Daily • 10/28/25
TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/22/25
TMDX Partners With Mercedes-Benz to Launch Organ Transport NetworkZacks Investment Research • 09/25/25
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in ItalyPRNewsWire • 09/22/25
TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 08/12/25
Heart Transplant Stock Rockets On $595 Million Sales Outlook, FDA ApprovalInvestors Business Daily • 08/05/25
TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart TrialPRNewsWire • 08/04/25